Evidence map›Paper›PMID 19854161›Full record

ArticleBiochemical pharmacology2010

Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes.

Nadine Schmidt, Andrea Pautz, Julia Art, Peter Rauschkolb, Matthias Jung, Gerhard Erkel, Mary B Goldring, Hartmut Kleinert

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Drug Candidates for Autoimmune Diseases.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  5. Curvularin Isolated FromFrontiers in microbiology · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Role of KSRP in control of type I interferon and cytokine expression.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2014
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Nadine SchmidtDepartment of Pharmacology, University Medical Center of the Johannes Gutenberg University Mainz, Obere Zahlbacher Strasse 67, D-55131 Mainz, Germany.
Andrea Pautz
Julia Art
Peter Rauschkolb
Matthias Jung
Gerhard Erkel
Mary B Goldring
Hartmut Kleinert
Johannes Gutenberg University Mainz · DEUniversity of Kaiserslautern · DEHospital for Special Surgery · USUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

Role of ESE1 Regulation of Type II Collagen in CartilageR01AG022021 · NIA · HOSPITAL FOR SPECIAL SURGERY · PI GOLDRING, MARY B · 2002 to 2014
$3.4M
NIA NIH HHS R01 AG022021
6 · The paper itself

Abstract

Chondrocytes are important for the development and maintenance of articular cartilage. However, both in osteoarthritis (OA) and rheumatoid arthritis (RA) chondrocytes are involved in the process of cartilage degradation and synthesize important immunomodulatory mediators, including nitric oxide (NO) generated by the inducible NO synthase (iNOS). To uncover the role of iNOS in the pathomechanisms of OA and RA, we analyzed the regulation of iNOS expression using immortalized human chondrocytes as a reproducible model. In C-28/I2 chondrocytes, iNOS expression was associated with the expression of the chondrocyte phenotype. Peak induction by a cytokine cocktail occurred between 6 and 8h and declined by 24h. Inhibition of p38MAPK, NF-kappaB and the JAK2-STAT-1alpha pathways resulted in a reduction of iNOS expression. In contrast to other cell types, the cytokine-mediated induction of the human iNOS promoter paralleled the induction rate of the iNOS mRNA expression in C-28/I2 chondrocytes. However, in addition post-transcriptional regulation of iNOS expression by the RNA binding protein KSRP seems to operate in these cells. As seen in other chondrocyte models, glucocorticoids were not able to inhibit cytokine-induced iNOS expression in C-28/I2 cells, due to the lack of the glucocorticoid receptor mRNA expression. In this model of glucocorticoid-resistance, the new fungal anti-inflammatory compound S-curvularin was able to inhibit cytokine-induced iNOS expression and iNOS-dependent NO-production. In summary, we demonstrate for the first time that differentiated human immortalized C-28/I2 chondrocytes are a representative cell culture model to investigate iNOS gene expression in human joint diseases.

Indexed as

Anti-Inflammatory AgentsCartilage, ArticularCell Line, TransformedChondrocytesCytokinesEnzyme InductionGene Expression Regulation, EnzymologicHumansInterferon-Stimulated Gene Factor 3Janus Kinase 2NF-kappa B p50 SubunitNitric Oxide Synthase Type IIp38 Mitogen-Activated Protein KinasesReceptors, GlucocorticoidRNA-Binding ProteinsRNA, MessengerAnti-Inflammatory AgentscurvularinCytokinesgamma interferon activation factorInterferon-Stimulated Gene Factor 3JAK2 protein, humanJanus Kinase 2KHSRP protein, humanNF-kappa B p50 SubunitNFKB1 protein, humanNitric Oxide Synthase Type IIp38 Mitogen-Activated Protein KinasesReceptors, GlucocorticoidRNA-Binding ProteinsRNA, MessengerTrans-ActivatorsZearalenone

Identifiers

PMID19854161
PMCPMC3951130
OpenAlexW2028855100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.